Nu-Med Plus Return on Equity (ROE) Growth & History (NUMD)
Nu-Med Plus's return on equity was −495.05% for fiscal 2021.
View full Nu-Med Plus company overviewNu-Med Plus annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2021 | 2021-12-31 | −495.05% | +3635.68 pp |
| 2020 | 2020-12-31 | −4,130.73% | — |
| 2018 | 2018-12-31 | −2,036.24% | — |
Nu-Med Plus quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2021 | 2021-06-30 | −256.31% | +3848.82 pp |
| Q1 2021 | 2021-03-31 | −108.33% | — |
| Q4 2020 | 2020-12-31 | −143.14% | — |
| Q3 2020 | 2020-09-30 | −143.33% | — |
| Q2 2020 | 2020-06-30 | −4,105.14% | — |
| Q4 2018 | 2018-12-31 | −280.61% | −11.01 pp |
| Q3 2018 | 2018-09-30 | −621.08% | — |
| Q1 2018 | 2018-03-31 | −624.70% | — |
| Q4 2017 | 2017-12-31 | −269.60% | — |
| Q3 2016 | 2016-09-30 | −350.12% | — |
| Q2 2016 | 2016-06-30 | −140.80% | — |
| Q3 2014 | 2014-09-30 | −210.65% | — |
| Q2 2014 | 2014-06-30 | −76.55% | — |
| Q1 2014 | 2014-03-31 | −356.87% | — |
Nu-Med Plus return on equity trends
Between the periods ended 2018-12-31 and 2021-12-31, Nu-Med Plus's return on equity increased from −2,036.24% to −495.05%, a change of +1541.19 percentage points. The latest reported quarter, Q2 2021, shows −256.31%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nu-Med Plus source filings ↗